Featured Story Startup Aims to Stop Spread of Cancer with Engineered Antibodies
With assistance from Johns Hopkins Technology Ventures, the team secured nearly $2 million in funding and hopes to test its therapy in patients in the next five years.
Insight Sept./Oct. 2021
Tapping Innovative Solutions and Technology at Johns Hopkins Medicine
Articles in this Issue
-
Use of Smartphone App for Heart Attack Survivors Is Associated with Lower Hospital Readmissions
During the 30-day study period, patients used the app for tracking medications, entering vital signs like weight and blood pressure, and viewing educational content.
